Rudy A C, Knight P M, Brater D C, Hall S D
Department of Medicine, Indiana University School of Medicine, Indianapolis.
J Pharmacol Exp Ther. 1991 Dec;259(3):1133-9.
Using stable isotope methodology, we studied the effect of the enantiomeric composition of dosage form on ibuprofen metabolism. Eight healthy human subjects received racemic ibuprofen (800 mg) plus S-[aromatic-2H4]ibuprofen (10 mg), R-ibuprofen (600 mg) plus S-[aromatic-2H4]ibuprofen (10 mg) and S-ibuprofen (600 mg) orally on separate occasions in random order. Stereoselective gas chromatography-mass spectrometry was used to quantify deuterated and nondeuterated ibuprofen in serum up to 24 h postdose. Urinary excretion of the stereoisomeric forms of carboxyibuprofen, hydroxyibuprofen and ibuprofen glucuronide were determined up to 24 h postdose by stereoselective high performance liquid chromatography. The metabolism of ibuprofen enantiomers was not influenced by the enantiomeric composition of the dose. For racemic ibuprofen, the mean clearances (+/- S.D.) of S-ibuprofen, R-ibuprofen inversion and R-ibuprofen noninversion were 87.4 +/- 25.9, 57.3 +/- 31.0 and 56.3 +/- 29.0 ml/min, respectively. The fractional inversion of ibuprofen was significantly greater (P less than .05) using the stereochemical composition of the urinary metabolites (0.63 +/- 0.05) vs. the method using the clearance of deuterated S-ibuprofen (0.51 +/- 0.08) after the dose of racemate. Unreliable estimates of fractional inversion were obtained when the S-ibuprofen and racemic ibuprofen doses were combined. Metabolite formation clearances suggested that S-ibuprofen is preferred over R-ibuprofen in the formation of hydroxyibuprofen, carboxyibuprofen and ibuprofen glucuronide. Product stereoselectivity in the formation of the four diastereomers of carboxyibuprofen was modest in favor of SS- and RR-carboxyibuprofen for S- and R-ibuprofen, respectively.
我们采用稳定同位素方法,研究了剂型的对映体组成对布洛芬代谢的影响。八名健康受试者分别随机口服消旋布洛芬(800毫克)加S-[芳环-2H4]布洛芬(10毫克)、R-布洛芬(600毫克)加S-[芳环-2H4]布洛芬(10毫克)和S-布洛芬(600毫克)。采用立体选择性气相色谱-质谱法对给药后24小时内血清中的氘代和非氘代布洛芬进行定量。采用立体选择性高效液相色谱法测定给药后24小时内羧基布洛芬、羟基布洛芬和布洛芬葡萄糖醛酸苷的立体异构体形式的尿排泄量。布洛芬对映体的代谢不受剂量对映体组成的影响。对于消旋布洛芬,S-布洛芬、R-布洛芬转化和R-布洛芬未转化的平均清除率(±标准差)分别为87.4±25.9、57.3±31.0和56.3±29.0毫升/分钟。与使用氘代S-布洛芬清除率的方法(0.51±0.08)相比,使用尿代谢物的立体化学组成(0.63±0.05)时,布洛芬的转化分数显著更高(P<0.05)。当将S-布洛芬和消旋布洛芬剂量合并时,获得的转化分数估计值不可靠。代谢物形成清除率表明,在羟基布洛芬、羧基布洛芬和布洛芬葡萄糖醛酸苷的形成中,S-布洛芬优于R-布洛芬。在羧基布洛芬的四种非对映异构体的形成中,产物立体选择性适中,分别有利于S-和R-布洛芬的SS-和RR-羧基布洛芬。